amiodarone has been researched along with Andersen Syndrome in 1 studies
Amiodarone: An antianginal and class III antiarrhythmic drug. It increases the duration of ventricular and atrial muscle action by inhibiting POTASSIUM CHANNELS and VOLTAGE-GATED SODIUM CHANNELS. There is a resulting decrease in heart rate and in vascular resistance.
amiodarone : A member of the class of 1-benzofurans that is 1-benzofuran substituted by a butyl group at position 2 and a 4-[2-(diethylamino)ethoxy]-3,5-diiodobenzoyl group at position 3. It is a cardiovascular drug used for the treatment of cardiac dysrhythmias.
Andersen Syndrome: A form of inherited long QT syndrome (or LQT7) that is characterized by a triad of potassium-sensitive periodic paralysis, VENTRICULAR ECTOPIC BEATS, and abnormal features such as short stature, low-set ears, and SCOLIOSIS. It results from mutations of KCNJ2 gene which encodes a channel protein (INWARD RECTIFIER POTASSIUM CHANNELS) that regulates resting membrane potential.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Mazzanti, A | 1 |
Guz, D | 1 |
Trancuccio, A | 1 |
Pagan, E | 1 |
Kukavica, D | 1 |
Chargeishvili, T | 1 |
Olivetti, N | 1 |
Biernacka, EK | 1 |
Sacilotto, L | 1 |
Sarquella-Brugada, G | 1 |
Campuzano, O | 1 |
Nof, E | 1 |
Anastasakis, A | 1 |
Sansone, VA | 1 |
Jimenez-Jaimez, J | 1 |
Cruz, F | 1 |
Sánchez-Quiñones, J | 1 |
Hernandez-Afonso, J | 1 |
Fuentes, ME | 1 |
Średniawa, B | 1 |
Garoufi, A | 1 |
Andršová, I | 1 |
Izquierdo, M | 1 |
Marinov, R | 1 |
Danon, A | 1 |
Expósito-García, V | 1 |
Garcia-Fernandez, A | 1 |
Muñoz-Esparza, C | 1 |
Ortíz, M | 1 |
Zienciuk-Krajka, A | 1 |
Tavazzani, E | 1 |
Monteforte, N | 1 |
Bloise, R | 1 |
Marino, M | 1 |
Memmi, M | 1 |
Napolitano, C | 1 |
Zorio, E | 1 |
Monserrat, L | 1 |
Bagnardi, V | 1 |
Priori, SG | 1 |
1 other study available for amiodarone and Andersen Syndrome
Article | Year |
---|---|
Natural History and Risk Stratification in Andersen-Tawil Syndrome Type 1.
Topics: Adolescent; Adrenergic beta-Antagonists; Adult; Amiodarone; Andersen Syndrome; Anti-Arrhythmia Agent | 2020 |